Finanzen von Longevity Health Holdings Inc (CTCX)CTCXLongevity Health Holdings Inc

Evaluating the bottom line, Carmell Corp maintains a gross margin of -11.20%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -6919.39%, while the net margin is -14028.37%. These profitability ratios, combined with a Return on Equity (ROE) of -87.09%, provide a clear picture of how effectively CTCX converts its operational activities into shareholder value.

In the context of the broader market, CTCX competes directly with industry leaders such as NITO and AXIL. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, CTCX's gross margin of -11.20% stands against NITO's 78.79% and AXIL's 72.02%. Such benchmarking helps identify whether Carmell Corp is trading at a premium or discount relative to its financial performance.